PET Dietary Supplements Market Size & Share Analysis - Growth Trends And Forecast (2025 - 2030)

Global Pet Dietary Supplements Market Trends and Insights

Surge in CBD-infused Supplement Launches

The United States CBD Product Safety and Standardization Act and European regulatory frameworks are simplifying market entry for CBD-infused pet products. In North America, 35% of pet dietary supplement consumers use CBD products in 2025, mainly for anxiety management and mobility support, and 22% of veterinarians recommend CBD supplements to address behavioral issues and joint health. The expanding CBD and hemp derivatives market is driving the development of products that combine calming and anti-inflammatory benefits.

Age-related Osteoarthritis in Senior Dogs

The formulation of hip and joint supplements is evolving to incorporate UC-II collagen and omega-3 combinations. Clinical studies show these formulations provide better mobility outcomes than glucosamine supplements, leading veterinarians to recommend multi-modal treatment approaches. The market growth is supported by pet owners' increasing focus on preventive care, particularly for senior pets.

Subscription-Based DTC E-commerce Models Expanding Average Order Value

Subscription-based platforms demonstrate an increase in average order value compared to single-purchase transactions. Auto-delivery programs implemented by companies facilitate systematic replenishment, ensuring consistent revenue streams while generating valuable consumption data for formula optimization and targeted promotional activities. This business model proves particularly effective for daily supplement categories, including calming aids, probiotics, and multivitamins, resulting in a market share transition from traditional retail establishments.

Veterinary Endorsement of Probiotic Formulas in Companion-Animal Clinics

Veterinary recommendations influence pet owners' purchasing decisions. Veterinary clinics are incorporating probiotics into standard wellness protocols, driving an increase in product launches. Products with age-specific probiotic strains, higher colony-forming unit (CFU) counts, and clinical documentation command premium pricing and strengthen veterinarian confidence.

Stringent FDA and NASC Compliance Extending Time-to-Market

The FDA's termination of its memorandum of understanding with AAFCO requires companies to obtain ingredient approvals or Generally Recognized as Safe (GRAS) status. This increases research and development costs and extends product launch timelines. The National Animal Supplement Council (NASC) Quality Seal has emerged as the primary compliance standard, requiring enhanced clinical evidence and independent testing. These regulatory requirements impact the pace of innovation, especially in CBD and functional botanical products.

Volatile Krill-oil Supply Chain Raising Input Costs

Climate disruptions and harvest restrictions in Antarctic fisheries increased krill-oil prices by 15-20% since 2023. The elevated costs reduced operational margins, compelling manufacturers to explore algal and plant-based omega-3 alternatives, which present challenges in palatability and nutrient density. Organizations implement supply chain transparency measures, including vessel monitoring and quota compliance verification, to address consumer requirements regarding sustainable sourcing.

Segment Analysis

By Product Form: Chewable Retain Loyalty, Liquids Drive Innovation

Chewable and soft chews dominate the pet dietary supplements market with a 39% share in 2024, primarily due to their flavor-masking capabilities and convenient dosing. Tablets and capsules maintain strong adoption in veterinary clinics, where precise dosage control and longer shelf life are essential. The liquid and gel segment shows the highest growth rate at 8.5% CAGR through 2030, particularly serving senior pets and those that have difficulty with solid supplements. Powders and dental chews complete the product range, offering multiple benefits such as joint support, calming effects, and skin health in single formulations. The market continues to evolve with new formats such as melt-in-mouth films for convenient administration.

The increasing focus on nutritional precision has driven innovations in dosage delivery, including liquid pump dispensers and cold-extrusion processes for chewables. Manufacturers address supply chain stability through dual-sourcing strategies for ingredients like gelatin and plant-based binders, while implementing sustainability certifications to meet retailer requirements. The emergence of combination supplement-snack products reflects consumer interest in functional treats, further strengthening the market position of chewable formats.

Note: Segment shares of all individual segments available upon report purchase

By Supplement Type: Multivitamins Anchor, CBD and Proteins Disrupt

Multivitamins hold 28.7% of the pet dietary supplements market share in 2024, serving as a primary entry point for consumers seeking comprehensive wellness solutions. The market shows increased diversification through condition-specific supplements, particularly in immune health and senior care categories. CBD and hemp derivatives demonstrate strong growth with a 10.4% CAGR, supported by improving regulations and their effectiveness in both anxiety reduction and mobility enhancement. Proteins and peptides, particularly collagen formulations, gain prominence in joint health and dermatological applications, with notable adoption in Asian markets where fish-derived collagen meets regional preferences. The market maintains steady demand for omega-3s, probiotics, antioxidants, and botanical ingredients in specialized formulations.

Research validation emerges as a significant factor, with expanding clinical evidence supporting collagen-vitamin C combinations and lipid-encapsulated CBD formulations. Advanced proteomic analysis techniques improve peptide bioavailability, creating clear differentiation between premium products and standard multivitamin offerings in the market.

By Function: Joint Health Dominates, Calming and Anxiety Relief Accelerates

Hip and joint health supplements accounted for 31.2% of the pet dietary supplements market size in 2024, driven by the increasing population of aging companion animals and pet owners' commitment to investing in long-term mobility solutions. Advanced formulations featuring UC-II collagen, green-lipped mussel, and boswellia serrata are replacing traditional glucosamine-only products, backed by clinical studies demonstrating improved pain reduction outcomes.^{[2]Frontiers in Veterinary Science, “Collagen Supplementation and Canine Mobility,” frontiersin.org}

The calming and anxiety relief segment is growing at a 9.7% CAGR, responding to increased pet stress levels following post-pandemic schedule adjustments. Products containing L-theanine, chamomile, and CBD combinations are becoming essential components in pet evening routines and travel preparations. Digestive health, weight management, and skin and coat care segments maintain steady growth in the mid-single digits, with advances in probiotic diversity and fiber formulations. The market share for calming supplements is projected to exceed 17% by 2030, reflecting the increasing emphasis on behavioral health in veterinary care. While currently specialized, renal and cardiovascular support products show growth potential, supported by research on SGLT2 inhibitors and parsley extracts improving kidney function in cats.

By Pet Type: Dogs Drive Volume, Cats Gain Strategic Focus

Dogs represented 45.7% of revenue in 2024, attributed to increased supplement adoption, demonstrated return on investment in preventive care, and expanded breed-specific product offerings. Joint health, digestive support, and dental care supplements constitute the primary canine segment, while weight management products increase in correlation with obesity rates. The cat segment, demonstrating a 7.1% CAGR, receives substantial research and development investment as manufacturers address specific dietary requirements and health conditions, notably chronic kidney disease. Enhanced palatability through advanced flavor systems addresses historically low supplement acceptance in cats.

Birds, small mammals, and exotic pets comprise specialized market segments with growth potential through specialty retail education and online community engagement. The market for feline kidney health supplements is projected to triple by 2030, supported by clinical validation of amino acid formulations. Multi-pet households utilize universal supplements, such as probiotic powders, enabling retailers to optimize inventory management.

Note: Segment shares of all individual segments available upon report purchase

By Distribution Channel: Specialty Stores Hold, Online Channels Surge

Specialty stores account for 42.3% of the pet dietary supplements market sales in 2024, attributed to their curated product selection and trained staff who provide supplement administration guidance. The strategic placement near premium pet foods and grooming services increases transaction values. The online channel demonstrates 12.6% CAGR growth, driven by subscription functionality, automated delivery discounts, and verified customer reviews that influence purchase decisions. The industry implements data analytics to generate supplement recommendations based on pet specifications and purchase patterns.

Veterinary clinics maintain their position as primary distributors of therapeutic supplements, including prescription renal formulations, while supermarkets facilitate the broad distribution of standard supplements such as multivitamins and dental products. Advanced logistics infrastructure and temperature-controlled distribution networks will facilitate the introduction of probiotic supplements and fresh formulations.

Geography Analysis

North America generated 48.4% of global revenue in 2024. The region's market leadership is attributed to high pet ownership rates, premium spending patterns, and a developed e-commerce infrastructure. Market expansion continues through increased veterinary adoption of functional ingredients and regulatory advancement regarding CBD supplements.^{[3] American Pet Products Association, “APPA National Pet Owners Survey,” americanpetproducts.org} Canada and Mexico contribute additional growth through expanding middle-income populations and preventive pet care education initiatives.

Asia-Pacific exhibits the highest growth trajectory with a projected 7.4% CAGR through 2030. China, Japan, and India drive regional expansion through urbanization, middle-class expansion, and increasing pet humanization trends. International manufacturers adapt through market-specific flavors, appropriate package sizes, and comprehensive retail strategies across diverse regulatory frameworks. 

Europe sustains market growth through Germany, the UK, and France, supported by stringent ingredient standards and a significant senior pet demographic. The market addresses consumer requirements for organic, plant-based, and scientifically validated formulations. South America, specifically Brazil, and the Middle East and Africa, particularly the UAE, demonstrate growth potential as Western consumption patterns expand through expatriate communities and digital market penetration.